SD2517 — An Act to promote transparency and prevent price gouging of pharmaceutical drug prices

SD2517 — An Act to promote transparency and prevent price gouging of pharmaceutical drug prices · Informed CitizenryThis bill proposes to increase transparency and oversight regarding pharmaceutical drug pricing in Massachusetts. It introduces new definitions for 'Biosimilar', 'Brand name drug', 'Pipeline drug',…Open in Informed Citizenry